Davies, C., Pan, H., Gray, R., Collins, R., Delmestri, A., Wang, Y., . . . Kielanowska, J. (2013). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Chicago-referens (17:e uppl.)Davies, C., et al. Long-term Effects of Continuing Adjuvant Tamoxifen to 10 Years Versus Stopping at 5 Years After Diagnosis of Oestrogen Receptor-positive Breast Cancer: ATLAS, a Randomised Trial. 2013.
MLA-referens (9:e uppl.)Davies, C., et al. Long-term Effects of Continuing Adjuvant Tamoxifen to 10 Years Versus Stopping at 5 Years After Diagnosis of Oestrogen Receptor-positive Breast Cancer: ATLAS, a Randomised Trial. 2013.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.